Peptide‐Driven Targeted Drug‐Delivery System Comprising Turn‐On Near‐Infrared Fluorescent Xanthene–Cyanine Reporter for Real‐Time Monitoring of Drug Release
- 12 August 2019
- journal article
- research article
- Published by Wiley in ChemMedChem
- Vol. 14 (19) , 1727-1734
Abstract
Targeted drug delivery (TDD) is an efficient strategy for cancer treatment. However, the real‐time monitoring of drug delivery is still challenging because of a pronounced lack of TDD systems capable of providing a near‐infrared (NIR) fluorescence signal for the detection of drug‐release events. Herein, a new TDD system, comprising a turn‐on NIR fluorescent reporter attached to an anticancer drug and targeting peptide, is reported. This system provides both TDD and NIR fluorescence monitoring of drug‐release events in target tissue. In this TDD system, a new carboxy‐derivatized xanthene–cyanine (XCy) dye is attached to an anticancer drug, chlorambucil (CLB), through a hydrolytically cleavable ester linker and coupled to a targeting peptide, octreotide amide (OCTA), which is specific to somatostatin receptors SSTR‐2 and STTR‐5 overexpressed on many tumor cells. This OCTA‐G‐XCy‐CLB (G: γ‐aminobutyric acid) conjugate exhibits no detectable fluorescence, whereas, upon the hydrolytic cleavage of the ester linker, a bright NIR fluorescence appears at λ≈710 nm; this signals release of the drug. Real‐time TDD monitoring is demonstrated for the example of the human pancreatic cancer cell line overexpressing SSTR‐2 and STTR‐5, in comparison with the noncancerous Chinese hamster ovary cell line, which contains a reduced number of these receptors.Keywords
This publication has 37 references indexed in Scilit:
- Gemcitabine–Coumarin–Biotin Conjugates: A Target Specific Theranostic Anticancer ProdrugJournal of the American Chemical Society, 2013
- A Unique Approach to Development of Near-Infrared Fluorescent Sensors for in Vivo ImagingJournal of the American Chemical Society, 2012
- Direct Fluorescence Monitoring of the Delivery and Cellular Uptake of a Cancer-Targeted RGD Peptide-Appended Naphthalimide Theragnostic ProdrugJournal of the American Chemical Society, 2012
- Selective esterase–ester pair for targeting small molecules with cellular specificityProceedings of the National Academy of Sciences, 2012
- Real-time monitoring of drug releaseChemical Communications, 2009
- Hydrolysis of acetylthiocoline, o‐nitroacetanilide and o‐nitrotrifluoroacetanilide by fetal bovine serum acetylcholinesteraseThe FEBS Journal, 2009
- Ring Size in Octreotide Amide Modulates Differently Agonist versus Antagonist Binding Affinity and SelectivityJournal of Medicinal Chemistry, 2008
- Phage display-derived peptides as therapeutic alternatives to antibodiesDrug Discovery Today, 2004
- Characterization of somatostatin receptor expression in human pancreatic cancer using real-time RT-PCRJournal of Surgical Research, 2004
- Synthesis, Biological Activities and Conformational Studies of Somatostatin AnalogsTetrahedron, 2000